(Q38988833)

English

Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Breno Satler Diniz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Antonio L Teixeira

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Marcia Radanovic

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Natalia Pessoa Rocha

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Wagner Farid Gattaz

7

object named as

Wagner Farid Gattaz

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Orestes V Forlenza

1

object named as

Orestes Vicente Forlenza

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Leda Leme Talib

5

object named as

Leda Leme Talib

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

3 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

NeuroMolecular Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

326-332

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Compensation and disease severity on the memory-related activations in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Development of a non invasive NGF-based therapy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Anticipated brain molecular aging in major depression

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Current concepts in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS12017-015-8361-Y

21 January 2018

Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12017-015-8361-Y

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138246%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38988833&oldid=2202426939"